Skip to main content

A single-shot treatment to protect infants from RSV may be coming soon

By NPR  
   February 02, 2023

AstraZeneca said its third phase trial results showed its single-dose treatment was nearly 75% effective at preventing severe infection in babies throughout an RSV season.

Full story


Get the latest on healthcare leadership in your inbox.